Business
Intelligent Bio Solutions Initiates Validation Study for Rapid Drug Screening Cartridge Targeting 70% Faster Results
Validation study targets sub-3-minute results to capture global roadside testing market and significantly reduce analysis time from 10 minutes U.S. Roadside drug testing market projected to reach $1.62 billion by 2030 NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the launch of a validation study aimed at significantly
About this update from Intelligent Bio Solutions Inc.
[{"type":"image","alt":"Intelligent Bio Solutions, Inc.","displaySize":"","headline":null,"caption":"Intelligent Bio Solutions, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":53,"url":"https://media.zenfs.com/en/globenewswire.com/9eadf03086af52dd7cf59a7dde9f27c4"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/u0ShMCptbSti3Wx.5JM3Ew--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTc0/https://media.zenfs.com/en/globenewswire.com/9eadf03086af52dd7cf59a7dde9f27c4","width":300,"height":53}},"lazy":false},{"type":"text","content":"Validation study targets sub-3-minute results to capture global roadside testing market and significantly reduce analysis time from 10 minutes ","length":142,"tagName":"p"},{"type":"text","content":"U.S. Roadside drug testing market projected to reach $1.62 billion by 2030","length":74,"tagName":"p"},{"type":"text","content":"NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the launch of a validation study aimed at significantly reducing the analysis time of its Intelligent Fingerprinting Drug Screening System.","length":385,"tagName":"p"},{"type":"text","content":"The study aims to improve the already rapid time-to-result of INBS's drug screening technology, which collects samples in under a minute and provides results within ten minutes at the point of collection. Faster results will enable INBS to target the global roadside drug testing market with a first-in-class solution.","length":322,"tagName":"p"},{"type":"text","content":""Speed matters in drug screening and is critical for roadside law enforcement,” said Harry Simeonidis, President and CEO at INBS. “Moving from a ten-minute test to under three minutes changes the entire value equation for our customers. This validation study aims to confirm our encouraging preliminary findings and advance us toward our two-minute test goal.”","length":365,"tagName":"p","attribs":{}},{"type":"text","content":"In the U.S. alone, roadside drug testing was valued at $1.17 billion in 2023 and is projected to reach $1.62 billion by 2030, growing at a compound annual growth rate of 4.71%1. The rise in prescription medications, recreational marijuana, and ...